Comparing outcomes of two methods for creating access points for dialysis.
Endovascular vs. Surgical Arteriovenous Fistula Outcomes
This study is looking at two ways to create access points for dialysis—one that's been used for a long time and a newer method—to see which one works better and has fewer problems for people needing dialysis.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10839297 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of two different methods for creating arteriovenous fistulas (AVFs) used in hemodialysis: the traditional surgical approach and a newer endovascular technique. The study aims to determine which method leads to better outcomes for patients requiring dialysis access. By conducting a randomized clinical trial, the research will compare the success rates and complications associated with each technique. Patients will be monitored for issues such as maturation failure and the need for additional procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic kidney disease who require hemodialysis and need vascular access.
Not a fit: Patients who are not candidates for hemodialysis or those who already have established and functioning vascular access may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dialysis access methods, enhancing patient outcomes and reducing complications.
How similar studies have performed: Previous pilot studies have shown promising results for the endovascular approach, but this research aims to provide definitive comparisons through a randomized trial.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Al-Balas, Alian — University of Alabama at Birmingham
- Study coordinator: Al-Balas, Alian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.